IDEAYA Biosciences Inc
NASDAQ:IDYA
IDEAYA Biosciences Inc
Cash Interest Paid
IDEAYA Biosciences Inc
Cash Interest Paid Peer Comparison
Competitive Cash Interest Paid Analysis
Latest Figures & CAGR of Competitors
Company | Cash Interest Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IDEAYA Biosciences Inc
NASDAQ:IDYA
|
Cash Interest Paid
$71k
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash Interest Paid
$42m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
5%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is IDEAYA Biosciences Inc's Cash Interest Paid?
Cash Interest Paid
71k
USD
Based on the financial report for Mar 31, 2024, IDEAYA Biosciences Inc's Cash Interest Paid amounts to 71k USD.
What is IDEAYA Biosciences Inc's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 5Y
-7%
Over the last year, the Cash Interest Paid growth was 42%. The average annual Cash Interest Paid growth rates for IDEAYA Biosciences Inc have been -4% over the past three years , -7% over the past five years .